Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages.

This study was concerned with the handling of ingested tubercle bacilli by normal human macrophages. Intracellular growth was determined after exposure of macrophages to viable bacilli in vitro and the effect of various cytokines, alone or in combination, on bacilli growth/survival was determined. It was found that Mycobacterium tuberculosis (M.tb) grew quite readily in untreated cultured human macrophages. Treatment with soluble factors showed that a crude lymphokine containing supernatant elicited with Concanavalin A (Con A) was ineffective at reducing growth of M.tb in vitro; similarly a crude lymphokine preparation from M.tb lysate-stimulated mononuclear cells failed to induce any mycobacteriostatic activity in human monocyte-derived macrophages. Recombinant cytokines were then evaluated for their ability to modulate growth of the tubercle bacilli in human macrophages. Recombinant interferon-gamma (IFN-gamma), interleukin-2 (IL-2) and recombinant interleukin 4 (IL-4) were all ineffective at modifying M. tuberculosis growth in human macrophages. Recombinant tumour necrosis-alpha (TNF-alpha) curbed the growth of the bacilli in human macrophages in a reproducible fashion. No cytokine combination was more efficient than TNF-alpha alone. These studies thus highlight the resistance of virulent mycobacteria against different mechanisms of cytokine-induced macrophage bactericidal activity.

[1]  A. J. Crowle,et al.  Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. , 1984, The American review of respiratory disease.

[2]  A. J. Crowle,et al.  Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages , 1989, Infection and immunity.

[3]  S. Kaufmann,et al.  Mycobacteria‐reactive Lyt‐2+ T cell lines , 1988, European journal of immunology.

[4]  I. Orme,et al.  Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. , 1984, Cellular immunology.

[5]  C. Nathan,et al.  A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. , 1983, Journal of immunological methods.

[6]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[7]  H. Murray,et al.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. , 1983, The Journal of clinical investigation.

[8]  R. Cotran,et al.  Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines. , 1987, Journal of immunology.

[9]  S. Kaufmann,et al.  The role of cell-mediated immunity in bacterial infections. , 1981, Reviews of infectious diseases.

[10]  M. Meltzer,et al.  Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. , 1988, Journal of immunology.

[11]  M. Horwitz,et al.  Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. , 1986, Journal of immunology.

[12]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[13]  G. Rook.  Progress in the immunology of the mycobacterioses. , 1987, Clinical and experimental immunology.

[14]  L. Bermudez,et al.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. , 1988, Journal of immunology.

[15]  B. Hudspith,et al.  Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon. , 1986, Tubercle.

[16]  Kendall A. Smith,et al.  T‐Cell Growth Factor , 1980, Immunological reviews.

[17]  S. Kaufmann,et al.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. , 1987, Journal of immunology.

[18]  B. G. Zurbrick,et al.  Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes , 1988, Infection and immunity.

[19]  G. Rook,et al.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.

[20]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[21]  A. Bøyum,et al.  Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .

[22]  H. Friedman,et al.  Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1. , 1989, Cellular immunology.

[23]  A. J. Crowle,et al.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.